Pharma Marketing Talk

Beyond Mobile Medical App Guidance

Pharmaguy

Pharmaguy

Call in to speak with the host

(347) 996-5894

What to Worry About After FDA Publishes Its "Final" Guidelines

A conversation with Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. We discuss prospects for FDA's final guidance on regulation of mobile medical apps (MMAs) and other regulatory issues that the mobile health community and FDA will need to face after publication of the "final" guidelines.

Tags:
Pharmaceutical
Health
Mobile
Marketing
FDA
Broadcast in Business
h:755
s:4610993
archived

Comments

 comments